State Of Wisconsin Investment Board Amylyx Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

  • $37.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.62 - $2.71 $361,619 - $604,931
-223,222 Reduced 61.71%
138,500 $263,000
Q1 2024

May 14, 2024
BUY
$2.71 - $19.57 $903,156 - $6.52 Million
333,268 Added 1171.25%
361,722 $1.03 Million
Q4 2023

Feb 12, 2024
BUY
$12.07 - $18.46 $33,301 - $50,931
2,759 Added 10.74%
28,454 $418,000
Q3 2023

Nov 14, 2023
SELL
$18.08 - $23.45 $115,314 - $149,564
-6,378 Reduced 19.89%
25,695 $470,000
Q2 2023

Aug 14, 2023
BUY
$20.98 - $31.42 $672,891 - $1.01 Million
32,073 New
32,073 $691,000

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $308M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email